Two Sigma Securities’s Evoke Pharma EVOK Stock Holding History

Two Sigma Securities’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,437	Closed	-$51.9K	–	1632
2025 Q3	$51.9K	Buy	+10,437	New	+$51.8K	0.01%	983
2021 Q4	–	Sell	-112	Closed	-$21K	–	1687
2021 Q3	$21K	Buy	+112	New	+$18.9K	﹤0.01%	1458
2019 Q2	–	Sell	-303	Closed	-$65K	–	2161
2019 Q1	$65K	Buy	+303	New	+$103K	﹤0.01%	1602
2018 Q4	–	Sell	-129	Closed	-$55K	–	2335
2018 Q3	$55K	Sell	129 -2	-2%	-$798	﹤0.01%	2356
2018 Q2	$47K	Buy	+131	New	+$49.1K	﹤0.01%	2520
2017 Q4	–	Sell	-77	Closed	-$37K	–	1795
2017 Q3	$37K	Buy	+77	New	+$29.7K	﹤0.01%	770

Two Sigma Securities's EVOK Position: Q4 2025 in Review

Two Sigma Securities sold out of Evoke Pharma (EVOK) in Q4 2025, closing a stake of 10,437 shares — an estimated $51.9K sold.

Two Sigma Securities first reported a position in EVOK in Q3 2017 and held it in 6 quarters. The position peaked at $65K in Q1 2019. 0 funds tracked by Wall St. Rank hold EVOK as of Q4 2025.

Two Sigma Securities reported no remaining Evoke Pharma position as of Q4 2025 after selling out during the quarter.
Two Sigma Securities sold 10,437 Evoke Pharma shares in Q4 2025, an estimated $51.9K.
Two Sigma Securities first reported a position in Evoke Pharma in Q3 2017 and held it in 6 quarters.
Two Sigma Securities's Evoke Pharma position peaked at $65K in Q1 2019.
0 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.